Both MK801 and NBQX reduce the neuronal damage after impact-acceleration brain injury

Journal of Neurotrauma

Volumn 19, Issue 11, 2002, Pages 1445-1456

  Goda, Makoto ^a   Isono, Mitsuo ^a   Fujiki, Minoru ^a   Kobayashi, Hidenori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Amyloid precursor protein; Fluoro Jade; Impact acceleration injury; MK 801; NBQX; Neuronal degeneration; Traumatic brain injury

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMYLOID PRECURSOR PROTEIN; DIZOCILPINE;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXONAL INJURY; BRAIN INJURY; CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NONHUMAN; RAT; TENSILE STRENGTH; TISSUE SECTION;

EID: 0036859644     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502320914679     Document Type: Article

References (32)

1. Agrawal, S.K., and Fehlings, M.G. (1997). Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J. Neurosci. 17, 1055-1063.
2. Ascher, P., and Nowak, L. (1998). Quisqualate- and kainate-activated channels in mouse central neurons in culture. J. Physiol. 399, 227-245.
3. Bullock, R. (1993). Opportunities for neuroprotective drugs in clinical management of head injury. J. Emerg. Med. 11, 23-30.
4. Foda, M.A.A.-E., and Marmarou, A. (1994). A new model of diffuse brain injury in rats. Part 2: Morphological characterization. J. Neurosurg. 80, 301-313.
5. Foster, A.C., and Wong, E.H.F. (1987). The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br. J. Pharm. 91, 403-409.
6. García-Barcina, J.M., and Matute, C. (1998). AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Mol. Brain Res. 53, 270-276.
7. Gurevich, B., Artru, A.A., Lam, A.M., et al. (1998). Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats. J. Neurosurg. 88, 1066-1074.
8. Hollmann, M., and Heinemann, S. (1994). Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
9. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 2552, 851-854.
10. Ikonomidou, C., and Turski, L. (1996). Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonists. Metab. Brain Dis. 11, 125-141.
11. Katayama, Y., Becker, D.P., Tamura, T., et al. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889-900.
12. Katoh, H., Sima, K., Nawashiro, H., et al. (1997). The effect of MK-801 on extracellular neuroactive amino acids in hippocampus after closed head injury followed by hypoxia in rats. Brain Res. 758, 153-162.
13. Koizumi, H., and Povlishock, J.T. (1998). Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 89, 303-309.
14. Lewén, A., Li, G.L., Olsson, Y., et al. (1996). Changes in microtubule-associated protein 2 and amyloid precursor protein immunoreactivity following traumatic brain injury in rat: Influence of MK-801 treatment. Brain Res. 719, 161-171.
15. Luel, M.S., Rhoney, D.H., Hughes, M., et al. (1996). New pharmacologic strategies for acute neuronal injury. Pharmacotherapy 16, 830-848.
16. Marmarou, A., Foda, M.A.A.-E., Brink, W.V.D., et al. (1994). A new model of diffuse brain injury in rats. Part 1: Pathophysiology and biomechanics. J. Neurosurg. 80, 291-300.
17. Mayer, M.L., MacDermott, A.B., Westbrook, G.L., et al. (1988). Agonist- and voltage-gated calcium entry in cultured mouse spinal cord neurons under voltage clamp measured using arsenazo III. J. Neurosci. 7, 3230-3244.
18. McDonald, J.H., Althomsons, S.P., Hyrc, K.L., et al. (1998). Oligodendrocytes from forebrain are highly vulnerable to AMPA/kinate receptor-mediated excitotoxicity. Nat. Med. 4, 291-297.
19. Okiyama, K., Smith, D.H., White, W.F., et al. (1998). Effects of NMDA antagonist CP-98, 113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat. Brain Res. 792, 291-298.
20. Povlishock, J.T., Marmarou, A., McIntosh, T., et al. (1997). Impact acceleration injury in the rat: Evidence for focal axolemmal change and related neurofilament sidearm alteration. J. Neuropathol. Exp. Neurol. 56, 347-359.
21. Regan, R.F., and Choi, D.F. (1994). The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res. 633, 236-242.
22. Rosenberg, L.J., Teng, Y.D., and Wrathall, J.R. (1999). 2,3-Dihydroxy-6-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci. 19, 464-475.
23. Schmued, L.C., Albertson, C., and Slikker, W., JR. (1997). Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
24. Sheardown, D.L., Nielsen, E.O., Hansen, A.J., et al. (1990). 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247, 571-574.
25. Siesjo, B.K. (1993). Basic mechanisms of traumatic brain damage. Ann. Emerg. Med. 22, 959-969.
26. Siverman, J.D., and Kruger, L. (1985). Projections of the rat trigeminal sensory nuclear complex demonstrated by multiple fluorescent dye retrograde transport. Brain Res. 361, 383-388.
27. Stahel, P.F., Morganti-Kossmann, M.C., and KossMann, T. (1998). The role of the complement system in traumatic brain injury. Brain Res. Rev. 27, 243-256.
28. Usowicz, M.M., Gallo, V., and Cull-Candy, S.G. (1989). Multiple conductance channels in type-2 cerebellar astrocytes activated by excitatory amino acids. Nature 339, 380-383.
29. Willis, C.L., Meldrum, B.S., Nunn, P.B., et al. (1993). Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline. Brain Res. 627, 55-62.
30. Wong, E.H.F., Kemp, J.A., Priestley, T., et al. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-asparrate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83, 7104-7108.
31. Wrathall, J.R., Choiniere, D., and Teng, Y.D. (1994). Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14, 6598-6607.
32. Yoshida, A., Dostrovsky, J.O., Sessle, B.J., et al. (1991). Trigeminal projections to the nucleus submedius of the thalamus in the rat. J. Comp. Neurol. 307, 609-625.